Alejandro Zamilpa is the director of Centro de Investigación Biomédica del Sur-Instituto Mexicano del Seguro Social (CIBIS-IMSS). Since joining the Mexican Social Security Institute (IMSS) in 1998, he has dedicated his scientific career to the development of new medications for the treatment of the most common ailments affecting Mexican society through a multidisciplinary research system. He completed his academic training at the Autonomous University of the State of Morelos, where he earned a Bachelor’s degree in Industrial Chemistry (1996), a Master’s degree in Chemical Sciences (1998), and a Doctorate in Chemistry (2003). He subsequently completed a postdoctoral fellowship in the Department of Pharmaceutical Chemistry at the University of Salamanca (Spain; 2003-2005). He has also participated in institutional research evaluation committees (Local Health Research Committee, National Health Research Committee, and Technical Committee of the Health Research Fund) and in various calls for proposals from the National Council of Science and Technology (Basic Science, Frontier Science, and Research Stays). He obtained the highest curricular distinction (Senior Researcher D) awarded by the Mexican Social Security Institute (IMSS) and Level 2 in the National System of Researchers, as well as the following awards: CANIFARMA 2005 (Technological Development), the Scientific Productivity Award (IMSS, 2015), and the IMSS Foundation grant (2016-2019).